Rapid IHC follows similar principles to traditional IHC but incorporates modifications to accelerate the process. It involves the application of primary antibodies to tissue sections to bind specific antigens. This is followed by a secondary antibody conjugated to a reporter enzyme or fluorophore. The key difference lies in the optimization of protocols, including the use of more concentrated antibodies, enhanced antigen retrieval techniques, and accelerated incubation times.
